1. The World Health Report 2003e. Geneva, Switzerland: World Health Organization 2003 (http:// www.who. int/whr/2003/en/Annex2-en.pdf).

2. Araujo MA, Goulart LR, Cordeiro ER, GattiRR, Menezes BS, Lourenco C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol 2005; 103(1):27-32.

3. Fernández-Arcás N, Dieguez-Lucena JL, Muñoz-Morán E, Ruiz-Galdón M, Espinosa-Caliani S, Aranda-Lara P, Rius-Diaz F, Gaitán-Arroyo MJ, De Teresa-Galván E, Reyes-Engel A. Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infaction. Clin Genet 2001; 60(1): 52-57.

4. Tregouet DA, Ricard S, Nicaud V, Arnould I,Soubigou S, Rosier M, Duverger N, Poirier O, Mace S, Kee F, Morrison C, Denefle P, Tiret L, Evans A, Deleuze JF, Cambien F. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 2004; 24(4): 775-781.

5. Acarturk E, Attila G, Bozkurt A, Akpinar O, Matyar S, Seydaoglu G. Insertion/deletion polymorphism of the angiotensin converting enzyme gene in coronary artery disease in southern Turkey. J Biochem Mol Biol 2005; 38(4): 486-490.

6. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 2003; 58(1): 1-9.

7. Lanz JR, Pereira AC, Lemos PA, Martinez E, Krieger JE. Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta 2005; 362(1-2): 176-181.

8. Nacak M, Davutoglu V, Soydinc S, Dinckal H, Turkmen S, Erbagci B, Akcay M, Aynacioglu S. Association between angiotensin converting enzyme gene polymorphism and coronary artery disease in individuals of the South-Eastern Anatolian population. Anadolu Kardiyol Derg 2004; 4(1): 45-51.

9. Shi YP, Meng WH, Shan J, Fu GS, Xu G. Polymorphism of angiotensin converting enzyme in Han populations and its relevance to the severity of coronary atherosclerosis (in Chinese). Zhejiang Da Xue Xue Bao Yi Xue Ban 2006; 35(3): 287-291.

10. Tsai CT, Hwang JJ, Ritchie MD, Moore JH, Chiang FT, Lai LP, Hsu KL, Tseng CD, Lin JL, Tseng YZ. Renin-angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene-gene interaction. Atherosclerosis 2007; 195(1): 172-180.

11. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330(23): 1629-1633.

12. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96(2): 687-692.

13. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J. Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1(3): 287-291.

14. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15(12): 1579-1592.

15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86(4): 1343-1346.

16. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51(1): 197-205.

17. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensinconverting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359(6396): 641-644.

18. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152(1): 56-64.

19. Goldbourt U, Yaari S, Medalie JH. Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17(1): 107-113.

20. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988; 8(6): 737-741.

21. Luciani MF, Denizot F, Savary S, Mattei MG, Chimini G. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 1994; 21(1): 150-159.

22. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257(1): 29-33.

23. Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol 2002; 13(4): 373-381.

24. Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking. Curr Opin Lipidol 2000; 11(5): 493-501.

25. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJ, Hayden MR. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103(9): 1198-1205.

26. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aouizerat BE, Cho MH, Fielding CJ, Kane JP. Analysis of hABC1 gene 5’ end: additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun 2000; 271(2):451-455.

27. Cenarro A, Artieda M, Castillo S, Mozas P, Reyes G, Tejedor D, Alonso R, Mata P, Pocovi M, Civeira F, Spanish FH group. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. J Med Genet 2003; 40(3):163-168.

28. Knowles JW, Reddick RL, Jennette JC, Shesely EG, Smithies O, Maeda N. Enhanced atherosclerosis and kidney dysfunction in eNOS(–/–)Apoe(–/–) mice are ameliorated by enalapril treatment. J Clin Invest 2000; 105(4): 451-458.

29. Miyahara K, Kawamoto T, Sase K, Yui Y, Toda K, Yang LX, Hattori R, Aoyama T, Yamamoto Y, Doi Y, Ogoshi S, Hashimoto K, Kawai C, Sasayama S, Shizuta Y. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem 1994; 223(3): 719-726.

30. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O’Shaughnessy KM, Brown MJ. A common variant of the endothelial nitric oxide synthase (Glu298.Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100(14): 1515-1520.

31. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31(7): 1506-1510.

32. Wang HU, Anderson DJ. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron 1997; 18(3): 383-396.

33. Winslow JW, Moran P, Valverde J, Shih A, Yuan JQ, Wong SC, Tsai SP, Goddard A, Henzel WJ, Hefti F, Beck KD, Caras IW. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 1995; 14(5): 973-981.

34. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13(3): 295-306.

35. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development 1999; 126(10): 2033-2044.

36. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13(9): 1055-1066.

37. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606-607.

38. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-densitylipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18(6):499-502.

39. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3): 1215.

40. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/dis equilibrium test. Am J Hum Genet 1998; 62(2): 450-458.

41. Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM, Tseng YZ. Lack of association between angiotensin-converting enzyme gene polymorphism and coronary heart disease in a Chinese population. Jpn Heart J 1997; 38(2): 227-236.

42. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 2000; 20(2): 484-492.

43. Sun P, Bo XP, Guo DP, Li XY, Hu ZB, Wang J, Li XR, Fan LM, Chen Q. Study on the association of ABCA1 gene common variants with the risk of coronary athero sclerotic heart disease (in Chinese). Zhonghua Xin Xue Guan Bing Za Zhi 2005; 33(7):627-630.

44. Evans D, Beil FU. The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipid aemia. J Mol Med 2003; 81(4): 264-270.

45. Balcerzyk A, Zak I, Krauze J. Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease. Acta Cardiol 2007; 62(3): 233-238.

46. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, Anabitarte A, Losada A, Medina A, Hernandez E, Fiuza D, Avalos O, Yunis C, Ferrario CM. Association of angiotensinogen M235T and A(–6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective cardiac gene. J Am Coll Cardiol 2001;37(6): 1536-1542.

47. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska - Czekajska T, Ksiazek A. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 2003; 58(1): 1-9.

48. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst 2005; 6(1): 38-42.

49. Gardemann A, Lohre J, Cayci S, Katz N, Till manns H, Haberbosch W. The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile. Atherosclerosis 2002; 160(1): 167-175.

50. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Car diol 2003; 41(6): 930-937.

51. Schneider MP, Erdmann J, Delles C, Fleck E, Regitz-Zagrosek V, Schmieder RE. Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens 2000; 18(12):1767-1773.